An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Official Title: An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.
NCT01357668
Klein-Gitelman, Marisa S., MD
Observational
Yes

Contact Information:

Marisa Klein-Gitelman, MD

Principal Investigator

312.227.6270